Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Denicoff

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lippincott'S Primary Care Practice|March 23, 2001
Chemoprevention research: implications for primary care practiceA M Denicoff, R M Padberg
Journal of the National Cancer Institute. Monographs|January 1, 1993
Nursing management of the patient receiving Taxol therapyM H Noone, M S McCabe, A M Denicoff, et al.
Investigational New Drugs|February 1, 1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancerN Ben-Baruch, A M Denicoff, B R Goldspiel, et al.
Cancer Nursing|April 1, 1993
Oncology nurse and physician attitudes toward aggressive cancer treatmentS Damrosch, A M Denicoff, D St Germain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancerS L Berg, A Tolcher, J A O'Shaughnessy, et al.
Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.
Anti-Cancer Drugs|October 1, 1992
Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatinL H Pai, S M Swain, D J Venzon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patientsJ A O'Shaughnessy, A M Denicoff, D J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancerL M Wakefield, J J Letterio, T Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lippincott'S Primary Care Practice|March 23, 2001
Chemoprevention research: implications for primary care practiceA M Denicoff, R M Padberg
Journal of the National Cancer Institute. Monographs|January 1, 1993
Nursing management of the patient receiving Taxol therapyM H Noone, M S McCabe, A M Denicoff, et al.
Investigational New Drugs|February 1, 1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancerN Ben-Baruch, A M Denicoff, B R Goldspiel, et al.
Cancer Nursing|April 1, 1993
Oncology nurse and physician attitudes toward aggressive cancer treatmentS Damrosch, A M Denicoff, D St Germain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Effect of R-verapamil on the pharmacokinetics of paclitaxel in women with breast cancerS L Berg, A Tolcher, J A O'Shaughnessy, et al.
Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.
Anti-Cancer Drugs|October 1, 1992
Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatinL H Pai, S M Swain, D J Venzon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patientsJ A O'Shaughnessy, A M Denicoff, D J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancerL M Wakefield, J J Letterio, T Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Pageof 2